|
| Feb 01,2010 |
Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2010 (Non-consolidated) (PDF59KB) |
|
| Dec 21,2009 |
Signing of Exclusive Licensing Agreement Concerning Gene Therapy with The University of Tokyo & TODAI TLO Ltd. and Re-granting Agreement with NOF Corporation Ltd. (PDF70KB) |
|
| Nov 19,2009 |
Development of sustained-release docetaxel, a new DDS formulation (PDF69KB) |
|
| Oct 30,2009 |
Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2010 (Non-consolidated) (PDF58KB) |
|
| Oct 13,2009 |
Comprehensive Joint Research Agreement with MEDINET for New Cancer Therapies (PDF71KB) |
|
| Sep 29,2009 |
[NOTICE] Issue of Sixth Series Warrant (PDF140KB) |
|
| Sep 07,2009 |
Professor Kataoka among Top 30 researchers in CSTP funding program (PDF19KB) |
|
| Jul 30,2009 |
Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2010 (Non-consolidated) (PDF56KB) |
|
| Jul 14,2009 |
Selection for Regional Innovation Creation R&D Project (PDF18KB) |
|
| Jun 15,2009 |
We release supplementary infomation to the release on May 25, 2009
"Signing of Exclusive Licensing Agreement Concerning Cationic Polyamino Acids with The University of Tokyo and TODAI TLO, Ltd." (PDF183KB) |
|
| May25,2009 |
Signing of Exclusive Licensing Agreement Concerning Cationic Polyamino Acids with The University of Tokyo and TODAI TLO, Ltd. (PDF38KB) |
|
| May14,2009 |
Financial Results for the year ended March 31, 2009(non-consolidated) (PDF232KB) |
|
| Feb 27,2009 |
Ichiro Nakatomi, Ph.D. CEO of NanoCarrier Co., Ltd. was elected as vice chairman of Licensing Executive Society Japan. (PDF60KB) |
|
| Feb 12,2009 |
Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2009 (non-consolidated)
Feb 12, 2009 (PDF67KB) |
|
Font size:
